Improve Medical Instruments Co., Ltd. (SHE:300030)
China · Delayed Price · Currency is CNY 6.35
+0.23 (3.76%)
Jul 31, 2026, 3:04 PM CST
SHE:300030 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 466.04 | 486.26 | 581.33 | 644.62 | 710.77 | 799.83 |
Revenue Growth | -16.14% | -16.35% | -9.82% | -9.31% | -11.14% | -12.99% |
Gross Profit Gross Profit Growth | 198.95 | 197.14 | 212.81 | 230.12 | 236.21 | 309.29 |
Operating Income Operating Income Growth | 54.66 | 36.67 | -29.91 | -33.5 | -60.91 | 32.89 |
Net Income Net Income Growth | 28.4 | 14.53 | -117.9 | -63.2 | -198.3 | 18.57 |
Earnings Per Share EPS Growth | 0.09 | 0.05 | -0.38 | -0.20 | -0.64 | 0.06 |
EPS Growth | - | - | - | - | - | -88.68% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medical Industry Medical Industry Growth | 482.63 | 576.58 | 637.82 | 702.35 | 787.89 |
Financial Leasing Financial Leasing Growth | 3.63 | 4.75 | 6.8 | 8.41 | 11.95 |
Total Total Growth | 486.26 | 581.33 | 644.62 | 710.77 | 799.83 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 168.11 | 160.32 | 248.96 | 237.71 | 224.05 | 345.74 |
Total Debt Total Debt Growth | 134.08 | 153.73 | 350.2 | 400.42 | 426.29 | 524.83 |
Net Cash (Debt) Net Cash Growth | 34.03 | 6.59 | -101.24 | -162.71 | -202.25 | -179.09 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.11 | 0.02 | -0.33 | -0.51 | -0.65 | -0.58 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 124.97 | 109.9 | 81.84 | 79.9 | 42.48 | 171.74 |
Capital Expenditures CapEx Growth | -25.21 | -24.12 | -51.28 | -43.7 | -58.04 | -71.05 |
Free Cash Flow Free Cash Flow Growth | 99.76 | 85.77 | 30.55 | 36.2 | -15.56 | 100.69 |
Free Cash Flow Growth | 207.55% | 180.72% | -15.60% | - | - | 19.22% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 42.69% | 40.54% | 36.61% | 35.70% | 33.23% | 38.67% |
Operating Margin | 11.73% | 7.54% | -5.15% | -5.20% | -8.57% | 4.11% |
Pretax Margin | 8.74% | 4.67% | -20.70% | -6.68% | -30.15% | 2.98% |
Profit Margin | 6.09% | 2.99% | -20.28% | -9.80% | -27.90% | 2.32% |
FCF Margin | 21.41% | 17.64% | 5.26% | 5.62% | -2.19% | 12.59% |
| Fiscal Year | FY 2021 |
|---|---|
| Period Ending | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.040 |
Dividend Per Share Growth | 25.00% |
Dividend Yield | 0.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 67.74 | 156.61 | - | - | - | 177.34 |
Forward PE | - | 29.05 | 29.05 | 29.05 | 29.05 | 29.05 |
P/FCF Ratio | 19.68 | 26.53 | 55.86 | 66.19 | - | 32.70 |
PS Ratio | 4.21 | 4.68 | 2.94 | 3.72 | 3.00 | 4.12 |